INIS
reduction
100%
patients
100%
doses
100%
psoriasis
100%
reviews
100%
diseases
50%
errors
50%
corrections
25%
interleukins
22%
implementation
9%
cost
6%
guidelines
6%
Keyphrases
Dose Reduction
100%
Plaque Psoriasis
100%
DR Strategies
50%
Low Disease Activity
50%
Apologizing
25%
Dose Reduction Strategies
13%
Psoriasis Severity
13%
Area Index
13%
Psoriasis Area
13%
Severity Index
13%
Interleukin-12 (IL-12)
13%
Interleukin-17 (IL-17)
13%
Dermatology Life Quality Index
6%
Interleukin
6%
Guselkumab
6%
Scoping Review
6%
Physician Global Assessment
6%
Medicine and Dentistry
Psoriasis Vulgaris
50%
Drug Dose Reduction
50%
Biological Product
50%
Psoriasis Area and Severity Index
10%
Interleukin 12
10%
Interleukin 17
10%
Tumor Necrosis Factor
7%
Guselkumab
5%
Cytokine
5%
Dermatology Life Quality Index
5%
Health Care Cost
5%
